Αρχική σελίδα » Γραμματεία » Ολες οι Ανακοινώσεις » Προβολή νέων

Προβολή νέων

14.09.2018

Πρόγραμμα του ΔΠΜΣ Νανοϊατρική/Nanomedicine

 

Πρόγραμμα του ΔΠΜΣ Νανοϊατρική/Nanomedicine

 

 


Date Day Title Lecturer hours Room



UNIT 1: Introduction to Nanotechnology (15 ECTS)





Lesson 1.1. Basic principles I


w1 10/15/2018 Mon 1.1.1 The wider context of Nanotechnology and Nanomedicine E. Efstathopoulos 5 Attiko

17/10/18 Wed 1.1.2 The Fundamental Science of Nanotechnology D. Tsoukalas 5 Pharma

19/10/18 Fri 1.1.2 The Fundamental Science of Nanotechnology D. Tsoukalas 5 Pharma










Lesson 1.2. Basic principles II


w2 22/10/18 Mon 1.2.1 Main types of nanosystems C. Demetzos - A. Pippa 5 Pharma

24/10/18 Wed 1.2.1 Main types of nanosystems H. Iatrou 5 Pharma

26/10/18 Fri 1.2.1 Main types of nanosystems H. Iatrou 5 Pharma







w3 29/10/18 Mon 1.2.1 Main types of nanosystems E. Spyratou, M. Gazouli, A,. Lyberopoulou 5 Pharma

31/10/18 Wed 1.2.2 Nanostructured materials M. Gazouli, A,. Lyberopoulou 5 Pharma

02/11/18 Fri 1.2.3 Physiochemical characterization techniques of nanosystems E. Spyratou 5 Pharma







w4 05/11/18 Mon 1.2.3 Physiochemical characterization techniques of nanosystems E. Spyratou 5 Pharma

07/11/18 Wed 1.2.3 Physiochemical characterization techniques of nanosystems H. Iatrou, A. Pippa 5 Pharma

09/11/18 Fri 1.2.4 Principles of Nanomedicine E. Efstathopoulos, A. Lyberopoulou 5 Attiko










Lesson 1.3. Basic principles III


w5 12/11/18 Mon 1.3.1 Short overview of in-vivo imaging techniques E. Efstathopoulos 5 Attiko

14/11/18 Wed 1.3.1 Short overview of in-vivo imaging techniques P. Karaiskos, E. Pantelis, A. Chatziioannou, E. Efstathopoulos 5 Attiko

16/11/18 Fri 1.3.1 Short overview of in-vivo imaging techniques N. Kelekis, E. Brountzos, S. Chatziioannou 5 Attiko







w6 19/11/18 Mon 1.3.1 Short overview of in-vivo imaging techniques N. Kelekis, E. Brountzos, S. Chatziioannou 5 Attiko

21/11/18 Wed 1.3.1 Short overview of in-vivo imaging techniques G. Tsivgoulis, S. Sgouros, S. Chatziioannou 5 Attiko

23/11/18 Fri 1.3.2. Future perspectives and challenges - Students’ project E. Efstathopoulos 5 Attiko







w7 30/11/18 Fri Exams of Unit 1 E. Efstathopoulos
Attiko










UNIT 2 : Applications of Nanotechnology in Medicine (15 ECTS)





Lesson 2.1. Basics of Nanomedicine


w8 03/12/18 Mon 2.1.1           Enabling technologies for oral drug delivery 3 h Reppas 5 Pharma



2.1.2           Introduction to pharmakocinetics (Absorption Distribution, Metabolism, Excretion) 2 h Karalis

05/12/18 Wed 2.1.3           Introduction to Quality by Design I and II 3 h Rekkas 5 Pharma



2.1.4           Choosing the optimal enabling formulation for oral drug delivery 2 h Reppas

07/12/18 Fri 2.1.5           Biorelevant in vitro performance of orally administrated dosage forms 2 h Vertzoni 5 Pharma



2.1.6           Modelling and simulation in drug development and approval 3 h Dokometzidis







w9 10/12/18 Mon 2.1.7           Solubility and solution properties of drugs 3 h Vertzoni 5 Pharma



2.1.8           Drug stability and principles of Pharmaceutical Technology 2 h Pippa


12/12/18 Wed 2.1.9           Introduction to the lipidic structures and to the crystalline state of matter 3 h Demetzos 5 Pharma



2.1.10           Introductions to Polymers in Pharmaceutics 2 h Iatrou


14/12/18 Fri 2.1.11         Introduction to modified release systems for drug delivery 3 h Vlachou 5 Pharma



2.1.12         Introduction to skin pathology and nanoparticulate’s penetration mechanism 2 h Rallis








w10 17/12/18 Mon 2.1.13           Nanomolecular diagnostics and in vitro diagnostics Papaparaskevas 5 Pharma

19/12/18 Wed 2.1.14         Biosensors, nanocrystals, quantum dots, magnetic nanoparticles II (applications) Mouzakis 5 Pharma

21/12/18 Fri 2.1.15          Imaging in interventional radiology 1 h Filippiadis-Spiliopoulos 5 Attiko



2.1.16        αναζήτηση βιβλιογραφίας (2 εσωτερικοί – 4 h)10 Mastorakos OK 2 ώρες











Lesson 2.2 Basic applications of nanotechnology in therapy


w11 08/01/19 Tue 2.2.1           Lipidic nanocarriers. Liposomes, chimeric lipidic nanoparticles and stimuli responsive C. Demetzos - A. Pippa 5 Pharma

09/01/19 Wed 2.2.2          Nanogels and polymeric micelles 3 h Iatrou 5 Pharma



2.2.4          Clinical therapeutics and nanotechnology 2 h Markantoni-Kyroudis

11/01/19 Fri 2.2.4           Nanoparticulate formulations and skin diseases 5 h Rallis 5 Pharma














w12 14/01/19 Mon 2.2.5           Introduction and applications to Theranostics 3h - MOUZAKIS – LYBEROPOULOU 5 Attiko



2.2.6        Applications of nanotechnology in nuclear therapy and in Radiotherapy 2 hKouloulias -Platoni)

16/01/19 Wed 2.2.7        Applications of nanotechnology in biophotonic therapy 3 h Kouloulias 5 Attiko



2.2.8          Applications of nanotechnology in vaccines 2 h Pippa

18/01/19 Fri 2.2.9          Applications of nanotechnology in surgery 2hTheothoropoulos, Nikiteas 5 Pharma



2.2.10  Αpplications of Nanotechnology in interventional radiology 1 h Fillippiadis - Spiliopoulos



2.2.11         Nanobubbles 2h Vavouranakis



Lesson 2.3 Theranostics and regenerative medicine


w13 21/01/19 Mon 2.3.1.         Applications of nanotechnology in Orthopaedics 3h Olga Savvidou 5 Attiko



2.3.2.         Physical properties of stimuli responsive biomaterials 2 hMouzakis

23/01/19 Wed 2.3.3.         Smart biomaterials 5h Iatrou, Mouzakis, Pippa 5 Pharma

25/01/19 Fri 2.3.4.         Types of embryonic, fetal and adult stem cells 5 h Roubelaki 5 Pharma







w14 28/01/19 Mon 2.3.5.         Application of smart biomaterials in regenerative medicine 5hN. Papaioannou - Triantafyllopoylos 5 Attiko

31/01/19 Thu 2.3.6.         Future perspectives and challenges (students’sproject 5h)
5 Pharma

01/02/19 Fri 2.3.7.         Implementation of M.Sc. Thesis G. Mastorakos, Th. Papaioannou, Pharma 5 Pharma







w15 08/02/19 Fri Exams of Unit 2

Pharma
























UNIT 3: Nano-toxicity and Regulatory aspects (10 ECTS)





Lesson 3.1. Toxicity aspects


w16 11/02/19 Mon 3.1.1. Potential cause of nanotoxicity M. Rallis 5 Pharma

13/02/19 Wed 3.1.2. Interaction of nanoparticles M. Gazouli, A. Lyberopoulou 5 Pharma







w17 18/02/19 Mon 3.1.3. Toxicity studies M. Gazouli 5 Pharma

20/02/19 Wed 3.2.1. Nanodrugs in clinical practice C. Demetzos, A. Pippa 5 Pharma







w18 25/02/19 Mon 3.2.1. Nanodrugs in clinical practice C. Demetzos, A. Pippa 5 Pharma

27/02/19 Wed 3.2.2. Advanced nanoparticle systems P. Bouzioti, S. Pispas 5 Pharma







w19 04/03/19 Mon 3.3.1. Nanomaterials and Manufacturing: framing the ethical issues D. Mouzakis 5 Pharma

06/03/19 Wed 3.3.2. Toxicology and human health, 3.3.3. Nanosimilars D. Mouzakis, C. Demetzos 5 Pharma







w20 13/03/19 Wed 3.3.4. Regulatory issues of nanomedicines (FDA, EMA) C. Gardikis 5 Pharma

15/03/19 Fri 3.3.5. Future perspectives and challenges - Students’ project M. Gazouli 5 Pharma







w21 18/03/19 Mon Presentation of Dissertation Protocols (students` presentations) E. Efstathopoulos, C. Demetzos, M. Gazouli 5 Attiko

20/03/19 Wed Presentation of Dissertation Protocols (students` presentations) E. Efstathopoulos, C. Demetzos, M. Gazouli 5 Attiko

3/22/2019 Fri Regulatory issues of nanomedicines and nanocosmetics
& applications of nanotechnology in cosmeotology
C. Gardikis 5
w22 29/03/19 Fri Exams of Unit 3

Pharma








APR - JUL/19
DISSERTATION (20 ECTS)










2-3/9/19
Exams

Attiko - Pharma

4-6/9/19
Dissertations' presentations

Attiko - Pharma